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ABSTRACT
The ongoing COVID-19 pandemic has greatly exacerbated mental health, which has long
been a growing problem in the United States; poor mental health not only jeopardizes the wellbeing of Americans but also has severe implications for America’s economy. Not only do mental
health conditions have significant costs of treatment, but the absenteeism, presenteeism, early
retirement, and mortality stemming from poor mental health also severely impact productivity.
One health policy that could alleviate this problem is Medicaid expansion. The Affordable Care
Act gave states the choice to expand Medicaid eligibility for individuals with incomes up to
138% of the federal poverty level. The resulting increases in health coverage, utilization, and
outcomes have been comprehensively examined by the literature; however, the association of
Medicaid expansion with mental health outcomes has only been tangentially explored. This
paper uses panel data from the Behavioral Risk Factor Surveillance System, American
Community Survey, and Wide-ranging Online Data for Epidemiological Research database to
analyze differences in mental health outcomes between expansion and non-expansion states.
Utilizing difference-in-differences regression models, I intend to estimate the effects of Medicaid
expansion on depression prevalence, suicides, and accidental drug overdose deaths. This study
finds that Medicaid expansion was associated with a significant increase in deaths from
unintentional overdose and depression prevalence. The link between expansion and suicides is
found to be inconclusive. These results hold widespread implications for mental health policy in
the United States.
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CHAPTER ONE
INTRODUCTION
I.

Mental Health in the United States
While much of the focus of the United States healthcare system has been on addressing

physical chronic conditions such as diabetes or cancer, mental illness has always been a critical
and growing threat to the health and well-being of Americans. From 2017 to 2018, the number of
adults with mental illness increased by 19%—a staggering addition of 1.5 million people (Mental
Health America, 2021). The ongoing COVID-19 pandemic has further exacerbated mental
illness to levels never seen before. Emotional distress caused by loved ones suffering through the
disease, stress resulting from lost opportunities caused by the pandemic, and social isolation
imposed by quarantine have had major adverse impacts on the mental health of Americans. From
June 2019 to June 2020, adults reported increased levels of mental illness, substance use, and
suicidal ideation (Czeisler et al., 2020). Furthermore, the prevalence of anxiety disorder tripled
and the prevalence of depressive disorder quadrupled. The problem of mental illness is not only
limited to adults; in fact, adolescents and older children are disproportionately affected by mental
health conditions. In 2017, over one-fifth of Americans aged 9-17 years had a diagnosable
mental health condition, with the most common being anxiety, mood, attention, and behavioral
disorders (Committee on Adolescent Health Care, 2017). Two prevalent mental disorders in the
US are Major Depressive Disorder (MDD), also known as depression, and substance use
disorder (SUD).
Depression is both prevalent and deadly in the US. In 2017, 17.3 million adults, 7.1% of
all adults, had at least one major depressive episode (National Institute of Mental Health, 2021a).
In that same year, over 3.2 million adolescents aged 12-17, 13.3% of all adolescents, had at least
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one major depressive episode. Depression, in turn, increases the risk of suicide—in fact,
“Depression and [SUD]s, mostly alcohol, are the most prevalent diagnoses among suicide
victims” (Brådvik, p. 1, 2018). Deaths from suicide are also far-reaching across the US. In 2019,
suicide was the tenth leading cause of death overall (National Institute of Mental Health, 2021b).
While suicides are a leading cause of death, drug overdoses are the leading cause of accidental
death, with opioids being the most common drug (Schiller et al., 2021).
Drug overdose rates have steadily increased since 1999, recently skyrocketing in the mid2010s because of the widespread misprescription and abuse of opioids. In 2019, 70,000
Americans died from a drug overdose with 40,000 dying from synthetic opioid misuse alone
(National Institute on Drug Abuse, 2021). Other major drugs involved in the overdose epidemic
are psychostimulants (e.g. methamphetamine), prescription opioids, benzodiazepines, and
antidepressants. The rising prevalence of depression and SUDs has greatly exacerbated rates of
suicide and drug overdose, respectively, in the US. The worsening state of mental health in the
US does not bode well for its economy either.

II.

Economic Impact of Mental Disorders in the United States
The growing crisis of mental health in the United States is of paramount concern to

economists because its direct negative effect on health outcomes has subsequent widespread
impacts on the American economy. The massive economic costs of mental disorders on
populations are both direct and indirect. While direct costs, costs that arise from treatment for
mental disorders in the healthcare system, are relatively easy to quantify, indirect costs, costs that
result from income losses and lost production, are much more difficult to measure (Trautmann et
al., 2016). For example, direct costs such as medical bills for hospitalization or medications are
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much more obvious than indirect costs that include the potential loss of productivity resulting
from work absence, early retirement, and even mortality.
Nevertheless, direct costs are only the tip of the iceberg when estimating the total
economic impact of mental disorders. Costs of treatment are proportionally lower compared to
the substantial losses that stem from lack of productivity and the resulting inhibition of economic
growth (Trautmann et al., 2016). Mental disorders are the leading causes of absenteeism,
presenteeism, sick leave, work accidents, unemployment, and early retirement (Pinheiro et al.,
2017). Greenberg et al. (2003) found that in 2000, the indirect costs of absenteeism,
presenteeism, and unemployment caused by depression in the US were 51.5 billion dollars,
comprising 62% of the total economic costs and over 5% of the country’s GDP at the time.
Furthermore, In 1995, the total economic costs of substance abuse were estimated to be 428.1
billion dollars, approximately 5.6% of the country’s GDP at the time. Clearly, mental illness is a
major impediment to economic growth; poor mental health leaves a huge indirect burden on
economic output. Thus, it is imperative to economists that mental illness be addressed. Recent
health legislation has given hope with regards to alleviating the current mental health crisis.

III.

History of Medicaid and Importance of Health Insurance
In 1965, President Lyndon B. Johnson signed the Social Security Amendments,

establishing two major healthcare programs that have since revolutionized the United States
healthcare system: Medicare and Medicaid. While both programs aim to provide health
insurance to groups of underserved individuals, they are funded by different governmental
sources. Medicare provides insurance primarily to elderly Americans aged 65 and older as well
as a small subset of younger Americans that have a qualifying disability status. This program

7

derives most of its funding from the federal government, mostly in the form of payroll taxes
(Centers for Medicare and Medicaid Services, 2021a). In contrast, Medicaid, which mainly
provides insurance to low-income Americans, is jointly funded by federal and state governments.
Specifically, the federal government pays a calculated percentage of Medicaid expenditures to
each state so that it can fund and manage its own unique version of Medicaid (Centers for
Medicare and Medicaid Services, 2021b).
Health insurance coverage is important to health outcomes because it has critical
implications for health service utilization. Freeman et al. (2008) conducted a systematic review
of just under 10,000 studies on empirical relationships between health insurance, utilization, and
outcomes, discovering that greater health insurance coverage consistently resulted in higher
utilization; greater utilization subsequently resulted in better outcomes. More specific to the
realm of mental health, mental health parity laws are legislation that requires equal treatment of
mental health conditions in insurance plans compared to physical conditions, with the intended
effect of increasing insurance coverage for patients with mental conditions. Research has shown
that these laws increase mental health care utilization 12 months after enactment (Harris et al.,
2006 as cited in Lang, 2010). There is not much research that has explored the effect of mental
health service utilization specifically on mental health outcomes. Nevertheless, we can assume
that the same causal relationship between utilization and outcomes applies to mental health
conditions as well.
Medicaid’s expansion of health insurance coverage holds positive implications for mental
health service utilization and outcomes. One recent major amendment to Medicaid, its expansion
under the Affordable Care Act (ACA), intends to increase coverage of Americans to an even
greater degree.
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IV.

Affordable Care Act and Medicaid Expansion
Signed by President Barack Obama in 2010 and fully implemented in 2014, the ACA

represented the US healthcare system’s most significant reform since the Social Security
Amendments by greatly expanding health insurance coverage and overhauling market
regulations for health insurance purchases (Centers for Medicare and Medicaid Services, 2021c).
20% of adults were uninsured in 2010 compared to 12% in 2016 (Collins et al., 2019).
Furthermore, gaps in coverage have decreased since the enactment of the ACA: 57% of adults
had a coverage gap of at least a year in 2012 compared with 31% of adults in 2018.
Perhaps the most controversial provision of the ACA was its expansion of eligibility for
citizens and legal residents with income up to 138% of the federal poverty line. In fact, the
Supreme Court ruled that forcing every state to implement Medicaid expansion was
unnecessarily coercive and allowed states to decide whether or not they wanted to expand or
continue at pre-ACA eligibility levels (National Federation of Independent Business v. Sebelius,
2011). Despite 12 states not having expanded Medicaid eligibility as of October 2021, numerous
studies conducted on the remaining 38 states have found that Medicaid expansion was associated
with significant increases in coverage, health service utilization, quality of care, and Medicaid
spending (Kaiser Family Foundation, 2021; Mazurenko et al., 2018). These effects have
subsequently led to better health outcomes overall for the residents of states that have expanded.
For example, one study found that expanding Medicaid eligibility resulted in a higher probability
of having low or mild psychological stress for low-income parents (McMorrow et al., 2016).
Another study found that increased Medicaid spending on antidepressants was associated with
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reductions in suicides for both adults and youth (Cueller & Markowitz et al., 2006). It is evident
that Medicaid expansion is associated with more favorable mental health outcomes.

V.
.

Contribution and Organization of this Paper
While the current literature has deeply explored the effect of Medicaid expansion on

health outcomes, it does not extensively cover the effect of mental health outcomes, specifically
mortality that results from poor mental health. These studies instead look at outcome variables
correlated with mental health, mainly the access and utilization of mental health care after
Medicaid expansion. Using data from the Centers for Disease Control and Prevention (CDC) as
well as the United States Census Bureau, this paper aims to investigate whether or not mental
illness mortality has changed in the states that have participated in Medicaid expansion. If
Medicaid expansion is ultimately beneficial to the US economy, it should lead to lower suicide
and drug overdose rates in the states that have expanded. Specifically, I would like to explore
how the outcome variables of depression prevalence, suicides, and drug overdose deaths are
affected by the predictor variable of state participation in Medicaid expansion. All three outcome
variables will be analyzed at the state level. The findings of this paper could potentially provide
another strong reason in the argument for states to adopt Medicaid expansion.
This paper will first review current existing literature on the effect of Medicaid expansion
on mental health care access, mental health utilization, and mental health outcomes. Next, data,
variable definitions, and econometric equations used for analysis will be described. Differencein-differences analyses will then be conducted. Following the analysis will be a presentation of
the results and a discussion of the findings. Lastly, the paper will draw conclusions, explain
possible implications, and give suggestions for future research.
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CHAPTER TWO
REVIEW OF MEDICAID EXPANSION AND MENTAL HEALTH OUTCOMES
This chapter provides a review of the current literature regarding the effect of Medicaid
expansion on access to mental health care and subsequent mental health outcomes. The chapter
will begin by describing the various determinants of mental health in order to explain the
associations between Medicaid expansion, mental health access and utilization, and eventual
mental health outcomes.

I.

Determinants of Mental Health
One of the most critical determinants of an individual’s mental health is their access to

mental health care. Due to the difficulty in observing and characterizing mental illness relative to
physical ailments, disorders involving mental health have long been faced with ignorance and
stigma. It was not until the 20th century, when many unfounded superstitions involving mental
illness were cast aside in lieu of scientific thought, that mental health care began advancing
rapidly in the United States (Foerschner, 2010). In recent years, access to mental health care has
increased, leading a growing number of people to seek treatment for mental illness. In 2018,
there were 55.7 million physician office visits and 4.9 million emergency department visits
concerning mental disorders (National Center for Health Statistics, 2021). However, in general,
access to healthcare has still been limited by Americans who are involuntarily uninsured. This is
because of the unique third-party payer system of the United States healthcare system, where
exorbitant medical costs have made it necessary for patients to enroll in insurance in order to
receive treatment, health insurance is critical for access to healthcare. Although Medicaid
provides insurance to over 71 million low-income Americans, a substantial proportion of low-
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income families still earn too much to be eligible for coverage, especially in states that have not
opted into Medicaid expansion (Centers for Medicare and Medicaid Services, 2020). This
coverage gap is of serious concern because it hinders access to care, which leads to lower health
service utilization and worse health outcomes.
Aside from access to healthcare, the quality of care received is also an important
determinant of mental health. A common economic method used to evaluate both the cost and
quality of different medical interventions is cost-effectiveness analysis, which calculates the
incremental cost-effectiveness ratio (ICER) of distinct methods of treatment. ICERs measure the
cost of a particular treatment relative to the quality-adjusted life-years (QALYs) which is a
measurement of both the quantity and quality of life lived (one QALY is equal to one year with
perfect health). Studies on the cost-effectiveness of primary care for depression have found that
it is generally very cost-effective. Although the interventions used in these studies vary in cost
and levels of intensity, all ICERs calculated between them fall in a narrow range from 10 to 35
dollars per depression-free day or 3,650 to 12,775 dollars per QALY gained (Schulberg, 1996;
Coulehan, 1997; Lave et al., 1998; Simon et al., 2001). This range is lower than that of
treatments for existing physical conditions, which have ICERs mostly ranging from 10,000 to
50,000 dollars per QALY gained (Cohen et al., 2008). When assessing the cost-effectiveness of
treatments for substance use disorders (SUDs), the literature almost solely explores treatments
for opioid use disorders. Fairley et al. (2021) found that most common treatments for opioid use
disorder were highly cost-effective, with methadone-only treatment costing 16,000 dollars per
QALY gained, methadone treatment combined with overdose education and naloxone
distribution costing 22,000 dollars per QALY gained, and buprenorphine treatment combined
with overdose education, naloxone distribution, and contingency management costing 42,000
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dollars per QALY gained. In general, the relatively low ICERs of mental health interventions
compared to those of physical health interventions demonstrates the lower cost and higher
quality of mental health care. However, the access, cost, and quality of mental health care can be
greatly impacted by socioeconomic and demographic factors, leading to indirect negative effects
on the mental health outcomes of Americans.
The social determinants of mental health describe the social, economic, and physical
environments of individuals, variable at each stage of life, that affect their mental health. Public
health experts reason that social determinants act by producing certain environmental stressors.
The persistence of these stressors chronically activates major neurosomatic stress pathways,
triggering adverse physiological responses in the brain and eventually leading to mental
disorders (Fisher & Baum, 2010). While the literature has explored a myriad of social
determinants that have been shown to affect mental health, determinants with the strongest and
most consistent associations with poor mental health for individuals include low income, low
education, unemployment, unmarried, female sex, and discrimination based on race, sex, sexual
orientation, and employment (Alegría et al., 2018; Compton & Shim, 2015; Coombs, 1991;
Sederer, 2016; Shim et al., 2014; Silva et al., 2016). Various social determinants of mental health
can not only have a direct physiological impact on the mental well-being of individuals, but can
also affect the care determinants of mental health: access, cost, and quality of mental health care.
Unemployment and income limit access to healthcare when health insurance cannot be afforded,
even despite Medicaid’s existence (Pharr et al., 2012). Stigma and discrimination, especially
against mental illness, may also limit access and quality of care. For example, language-based
discrimination and negative attitudes toward professional mental health services were associated
with a lower likelihood of Chinese Americans seeking out professional mental health treatment
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(Spencer & Chen, 2004). Overall, both the social and medical determinants of mental health
must be addressed when studying mental health outcomes because they all affect an individual’s
mental well-being.

II.

Impact of Medicaid Expansion on Access and Utilization of Mental Health Care
As of April 2021, over 75.4 million Americans are enrolled in Medicaid. This represents

a 36.1% increase compared with the baseline of 55.4 million Americans in December 2013, right
before states began expanding their Medicaid programs (Centers for Medicare and Medicaid
Services, 2021d; Snyder et al., 2014). Even before the ACA Medicaid expansion, previous
expansions of Medicaid eligibility were shown to significantly improve health coverage and
access to care. McMorrow et al. (2016) explored the effect of previous non-ACA expansions of
Medicaid eligibility from 1997 to 2009. They found that for every 100 percentage point increase
in the income threshold for eligibility, there was a 10.5 percentage point increase in the
proportion of low-income parents with Medicaid. The positive effect of the ACA Medicaid
expansion on health insurance enrollment is directly observed in Courtmanche et al. (2016).
Using difference-in-differences analysis, they found that full implementation of the ACA
increased the percentage of insured individuals by 5.9 percentage points in states that opted into
Medicaid expansion compared with an increase of only 2.9 percentage points in states that did
not opt in. Furthermore, a systematic review of 304 studies exploring the effect of Medicaid
expansion on access to care found that three-quarters of the analyses reported increased coverage
among all potentially eligible individuals, even when controlling for major social determinants of
health including race/ethnicity, age, marital status, and income (Mazurenko et al., 2018).
Evidently, Medicaid expansion has greatly improved general health insurance coverage since its
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implementation. This trend not only applies to those with physical illness, but also to individuals
with mental health disorders.
More specific to the realm of mental health, a few studies have explored the effect of
Medicaid expansion on access to care for patients with mental disorders. Blazoski & Maio
(2021) found that Medicaid expansion was associated with an increase in the coverage of
individuals with mental health disorders and SUDs. Fry & Sommers (2018) found that Medicaid
expansion was associated with a significant decrease in the proportion of depressed adults that
were uninsured. However, it should be noted that the sample size of this study was relatively
small at 5,000 respondents and there was a low survey response rate of 22% which could be
subject to nonresponse bias. With regards to Medicaid expansion’s impact on access to
treatments for SUDs, the evidence generally supports that the effect is positive. Sharp et al.
(2018) found that prescriptions of buprenorphine and naltrexone, two common treatments for
opioid use disorder, skyrocketed by more than 200% after states opted into Medicaid expansion.
Another study found that states that opted into expansion had 78.2 more prescriptions per year
for naloxone, used to treat opioid overdose, compared with states that did not opt in (Frank &
Fry, 2019). However, it is unclear if an increase in the use of naloxone could be due to a
worsening of the United States opioid epidemic, which would increase the likelihood of opioid
overdose and subsequent administration of naloxone.
By improving health coverage, one could argue that Medicaid expansion has also
increased the utilization of mental health services. The literature has generally supported this
trend. Han et al. (2020) used a difference-in-differences approach on data collected from the
Medical Expenditures Panel Survey from 2007 to 2015, finding that yearly outpatient visits for
mental health conditions increased by 0.513 visits per person in states that expanded. However,
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this increase was only limited to Hispanics and Non-Hispanic Whites—there was no change in
outpatient visits observed among Non-Hispanic Blacks. Furthermore, there was no significant
change in the number of mental health-related hospital stays, emergency department visits, or
prescription fills and no significant increase in the number of users of outpatient mental care,
which demonstrates that Medicaid expansion may have not had a significant contribution to
mental health care access. In contrast, another study conducted a year later using the Healthcare
Cost and Utilization Project’s Fast Stats Database found that Medicare expansion was associated
with a slight but significant increase of 0.35 non-Medicare emergency department visits by
adults with mental disorders per 1,000 people (Jayawardhana, 2021). Compared to Han et al.,
this study also observed a larger time period, from 2006 to 2019, which bolsters the accuracy of
its findings. The literature provides conflicting results on the effect of expansion on the
utilization of common treatments for SUDs. Wen et al. (2017) found that Medicaid expansion
was associated with a 70 percent increase in buprenorphine prescriptions covered by Medicaid.
Furthermore, Grooms & Ortega (2019) found that expansion was associated with a substantial
increase in Medicaid-covered SUD treatment admissions. While these two studies support that
expansion has increased utilization of SUD treatments, Creedon & Cook (2016) caution that the
link between access and utilization of care is not always guaranteed. They found that increases in
mental health treatment for Hispanics and Asians were not significantly greater than what was to
be expected given earlier trends in mental health treatment. In contrast to the studies described
above, they also found that there were no significant changes in the treatment of substance use
disorders. However, this study was conducted during the beginning of Medicaid expansion and
the more-recent studies described previously have found marked increases in the utilization of
mental health care. Overall, the literature supports that Medicaid expansion increases not just
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general health coverage, but mental health coverage as well. This will likely improve mental
health outcomes as more Americans will have access to and utilize treatment for mental
disorders.

III.

Impact of Medicaid Expansion on Mental Health Outcomes
The major health variables described previously in this review (mental health care

coverage, access, and utilization) all have a close and positive association with mental health
outcomes. The few studies that have explored the relationship between Medicaid expansion and
mental health outcomes have overwhelmingly shown it to be positive. Studies investigating
general mental health have found that expansion was associated with lower psychological
distress, fewer poor mental health days, and a lower likelihood of reporting declines in mental
health for individuals with low income (Blazoski & Maio, 2021; McMorrow et al., 2016,
McMorrow et al., 2017).
With regards to Medicaid expansion’s effect on the outcomes concerning more specific
mental illnesses, Baicker et al. (2013) conducted a randomized, controlled study that found
Medicaid coverage to decrease the probability of a positive screening for depression. Thus, we
may infer that Medicaid expansion, which results in higher Medicaid coverage, will decrease an
individual’s probability of depression. The literature has also found that Medicaid expansion was
associated with 1.2 fewer suicide deaths per 100,000 people (Austin et al., 2021). However, this
study had a relatively small sample size of 8 Medicaid expansion states and 7 non-expansion
states. Furthermore, although it did control for race, it did not take the other major social
determinants of mental health such as employment, income, and marital status into account,
which could cause omitted variable bias. Practically all of the literature looking at the effect of
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Medicaid expansion on SUD overdose mortality have only studied deaths from opioids; their
findings are conflicting. One study found that counties in expansion states were associated with a
6 percent lower rate of opioid overdose deaths relative to the rate in counties of non-expansion
states. Specifically, expansion states had an 11 percent lower rate of death involving heroin, and
a 10% lower rate of death involving synthetic opioids other than methadone (Kravitz-Wirtz et al.,
2020). However, there was also an 11% increase in methadone-related overdose deaths in
expansion states. In contrast, Averett et al. (2019) found that Medicaid expansion had no
significant effect on opioid deaths. While Yan et al. (2020) found that expansion was associated
with a 1.9 percent reduction in mortality not due to drug overdose, it found that drug overdose
deaths actually rose more sharply in expansion versus non-expansion states. It seems that the
United States opioid epidemic is to blame, as it could blunt the mortality benefit of Medicaid
expansion. Even though the impact of Medicaid expansion on SUD outcomes is unclear, the
literature has demonstrated that expansion is associated with better outcomes for depression.

Whereas the literature has provided context for the effect of Medicaid expansion on
mental health trends, including its generally positive association with access to mental health
care, utilization of mental health care, and mental health outcomes, this paper uniquely and more
specifically explores the impact of expansion on variables concerning mental illness mortality
from mental disorders. It aims to evaluate mental health outcome variables that are closely
associated with, but not exactly, the variables that have been extensively explored in the
literature.
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CHAPTER THREE
OVERVIEW OF DATA SOURCES
I.

Behavioral Risk Factor Surveillance System
This study partly uses data taken from the 2011-2020 Behavioral Risk Factor

Surveillance System (BRFSS) which is managed by the CDC and administered by the health
departments of individual states. Data on mental illness prevalence, specifically depression
prevalence, is taken from this survey.
BRFSS obtains data through yearly, individual-level, cross-sectional health-related
telephone surveys that are administered in all 50 states, the District of Columbia, and three
United States territories. Respondents answer questions on health-related risk behaviors, use of
chronic health services, and use of preventive health services (Centers for Disease Control and
Prevention, 2014). Data collected from surveys is then weighted using the iterative proportional
fitting methodology, also known as raking. This method enables the introduction of demographic
variables such (e.g. marital status, level of education) into the statistical weighing process to
reduce the likelihood of bias and increase the representativeness of estimates.

II.

American Community Survey
This study also uses data taken from the 2010-2019 American Community Survey (ACS)

administered by the United States Census Bureau. Data taken from this survey include sex,
marital status, employment status, education level, income, and the race/ethnicity of Americans
at the individual level and aggregated to the state level.
Every year, the ACS is sent to a sample of random addresses, about 3.5 million, in the 50
states, District of Columbia, and Puerto Rico (United States Census Bureau, 2021a). Each

19

address has a 1 in 480 chance of being selected, and no address is selected more than once every
five years. Data is collected by internet, mail, telephone interviews, and in-person interviews.
Ultimately, about 95 percent of all households surveyed respond (United States Census Bureau,
2021b). The survey gathers demographic, economic, and social characteristics of Americans.
The United States Census Bureau aggregates individual responses to the ACS into estimates at
many geographic levels, including states, counties, cities, and congressional districts. 1-year
estimates, which will be used in this paper, are available for areas with populations of at least
65,000 people.

III.

CDC Wonder
Data on mental health mortality (suicides, drug overdoses) is taken from the CDC’s

Wide-ranging Online Data for Epidemiological Research (WONDER) database.
The specific aspect of the database that was used is the Underlying Cause of Death
category, which contains county-level national mortality and population data from 1999-2020.
This data will be aggregated to the state level. Data on mortality is collected from death
certificates of United States residents, which include information about a single underlying cause
of death as well as demographic data. An underlying cause of death is defined by the World
Health Organization as "the disease or injury which initiated the train of events leading directly
to death, or the circumstances of the accident or violence which produced the fatal injury”, and is
selected from conditions entered by a physician on the cause of death section of a death
certificate (World Health Organization, 2021 as cited in Centers for Disease Control and
Prevention, 2021). Mortality data is coded as “suppressed” when it is sub-national and fewer
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than 10 individuals (for confidentiality reasons). When the death count is fewer than 20,
mortality data is coded as “unreliable”.

21

CHAPTER FOUR
ECONOMETRIC METHOD
I.

Econometric Model
This study employs a difference-in-differences regression model to investigate the effect

of Medicaid expansion on mental health outcomes. The quasi-experimental design of this
technique compares the panel data from treatment and control groups to estimate the effect of a
specific intervention on population outcomes. In this paper, the treatment group consists of
counties in states that opted into Medicaid expansion and the control group consists of counties
in states that did not participate in the expansion. The model enables us to infer causality for the
effect of a policy intervention. The model will be used to study the state-level dependent
variables of suicides, deaths from accidental overdose, and depression prevalence.

Model: 𝑦ist = 𝛽0 + 𝛿1EXPANDEDst + 𝛽1COVERAGEist + 𝛽2FEMALEist + 𝛽3MARRIEDist +

𝛽4EMPLOYEDist + 𝛽5EDUCATIONist + 𝛽6INCOMEist + 𝛽7BLACKist + 𝛽8ASIANist +
𝛽9OTHERist + µs + 𝜆t + 𝜀ist

Where 𝑦ist is the outcome for state s in year t, µs represents state fixed effects that control
for differences between states, 𝜆t represents year fixed effects that control for differences
between years, and 𝜀icst is the error term. The coefficient of interest is 𝛿1, which estimates the
effect of Medicaid expansion on mental health outcomes in an expansion state after expansion
has been implemented in that state. We estimate four specifications for each dependent
variable—Specification 1 does not include state or year fixed effects, Specification 2 includes
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only state fixed effects, Specification 3 includes only year fixed effects, and Specification 4
includes both state and year fixed effects.

II.

Variable Definitions

Dependent Variables:
Suicides

State-level variable - the average number of
suicides per 100,000 population in a state
per year

Overdoses

State-level variable - the average number
of unintentional overdose deaths per
100,000 population in a state per year

Depression prevalence

State-level variable - the percentage of
individuals with depression in a state per
year

Independent Variables:
EXPANDED

Equals 1 if Medicaid expansion is in effect
in a particular state during a particular year
and 0 otherwise

COVERAGE

Percentage of individuals covered under
health insurance other than Medicaid in a
state

FEMALE

Percentage of population in a state that is
female

MARRIED

Percentage of population in a state that is
married
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EMPLOYED

Percentage of population in a state that is
employed

EDUCATION
9

Percentage of population in a state whose
highest educational attainment is less than
9th grade

HS

Percentage of population in a state whose
highest educational attainment is graduating
high school

C

Percentage of population in a state whose
highest educational attainment is some
college with no degree

INCOME
10

Percentage of population in a state whose
income in past year was less than or equal to
$9,950

12

Percentage of population in a state whose
income in past year was $9,951 to $40,525

22

Percentage of population in a state whose
income in past year was $40,526 to $86,375

24

Percentage of population in a state whose
income in past year was $86,376 to
$164,925

32

Percentage of population in a state whose
income in past year was $164,926 to
$209,425

35

Percentage of population in a state whose
income in past year was $209,426 to
$523,600
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BLACK

Percentage of population in the state that
is black

ASIAN

Percentage of population in the state that
is Asian or a Pacific Islander

OTHER

Percentage of population in the state that
is a race/ethnicity that is not white, black,
or Asian

III.

Variable Explanations
The EXPANDED dummy variable differentiates whether or not the data pertains to the

time after a state has opted into Medicaid expansion. Thus, the coefficient on EXPANDED (𝛿1)
isolates the effect of Medicaid expansion implementation. Because some states have opted into
Medicaid expansion during times of the year other than January 1, this is accounted for by
coding the number of days after the beginning of the year which expansion was implemented in
such states as a fraction of EXPANDED. For example, New Hampshire implemented Medicaid
expansion on August 15, 2014. Because this is 226 days after January 1, 2014, the value of
EXPANDED for New Hampshire in 2014 would be coded as (365-226)/365 or 0.381 since the
policy was only in effect for 38.1% of the year.
The literature has shown that access to healthcare is a critical determinant of mental
health. Thus, COVERAGE controls for this by describing the proportion of individuals covered
by health insurance. Other non-healthcare-related determinants of mental health include social
determinants, which have also been extensively explored in the literature. Income, level of
education, employment status, marital status, sex, and race/ethnicity have all been shown to
affect mental health (Alegría et al., 2018; Compton & Shim, 2015; Sederer, 2016; Shim et al.,
2014; Silva et al., 2016). Thus, variables measuring these determinants are included in the
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regression model to control for their effects on the outcomes. Specific variables of EDUCATION
describe the highest level of educational attainment of an individual. Specific variables of
INCOME describe the income earned by an individual in the last 12 months. FEMALE,
MARRIED, and EMPLOYED, control for sex, marital status, and employment status,
respectively. BLACK, ASIAN, and OTHER are variables that control for the effect of
race/ethnicity on the outcomes.
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CHAPTER FIVE
DATA SELECTION, DESCRIPTION, AND LIMITATIONS
I.

Selection of the Sample
Three state-level samples were used in this study to estimate overdoses, suicides, and

depression prevalence, respectively. The samples measuring suicides and depression prevalence
are each comprised of all 50 states and the District of Columbia. The sample measuring
overdoses is comprised of 49 states and the District of Columbia. The only state not included is
Wyoming, as there was insufficient data on overdoses in Wyoming. All samples contain data
over a 9-year period from 2011 to 2019. All data management was conducted through Stata BE.
The sample was first produced as a raw data extract using the Integrated Public Use Microdata
Series (IPUMS). ACS individual 1-year estimate data on the demographic variables of interest
were obtained from IPUMS, recoded in accordance with my variable definitions, and aggregated
into state-level averages. Yearly county-level data on overdoses and suicides were obtained from
CDC Wonder, recoded, appended, and merged with the ACS data to create our final samples for
overdoses and suicides. Yearly individual-level data on depression prevalence were obtained
from the CDC website, recoded, appended, and merged with the ACS data to create our final
sample for depression prevalence.

II.

Descriptive Statistics
Table 1 presents the descriptive statistics for the sample measuring overdoses. There

were an average of 21 deaths from unintentional overdose per 100,000 population per state per
year from 2011 to 2019. Overdoses ranged from as little as 1.7 deaths to as high as 150 deaths
per 100,000 population. Table 2 presents the descriptive statistics for the sample measuring
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overdoses. There were an average of 16 suicides per 100,000 population per state per year from
2011 to 2019. Suicides ranged from as little as 4.3 deaths to as high as 61 deaths per 100,000
population. Table 3 presents the descriptive statistics for the sample measuring overdoses. On
average, the depression prevalence per state per year was 19% from 2011 to 2019. Depression
prevalence ranged from as little as 0% to as high as 50% among the states.
All three samples have very similar descriptive statistics for the demographic variables
measured. For each sample, the average proportion of individuals in each state who are female is
48%. The average proportion who are married is approximately 58%, while the average
proportion who are employed is about 94%. The average proportion who are covered under
health insurance other than Medicaid is approximately 80%. Among the various dummy
variables for education, most individuals received at least a college education (about 32% of
individuals had some college education with no degree). Among the various dummy variables
for income, the highest proportion of individuals (about 42%) earned an income in the 12% tax
bracket ($9,951 to $40,525).

III.

Limitations of the Data
For the ACS data, individuals who were neither employed nor unemployed (i.e. not the

labor force) were dropped as they did not fit the EMPLOYED variable definition. For the CDC
Wonder data, counties in which the number of overdoses or suicides were too low and coded as
“unreliable” or “suppressed” were dropped in their respective samples. The nonrandom filtering
out of some observations may have caused the data from my samples to be less representative of
the actual United States population since missing observations were disproportionately
distributed among states.
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CHAPTER SIX
REGRESSION OF MENTAL HEALTH OUTCOMES ON MEDICAID EXPANSION
Each of the three estimated regressions contains four specifications. Specification 1 does
not contain state or year fixed effects. Specification 2 contains only state fixed effects.
Specification 3 contains only year fixed effects. Specification 4 contains both state and year
fixed effects.

I.

Effect of Medicaid Expansion on Overdoses
Estimates from the difference-in-differences regression on the effects of Medicaid

expansion on deaths from unintentional overdose are presented in Table 4. Controlling for sex,
marital status, employment status, healthcare insurance coverage status, race, educational
attainment, and income level, expansion had a significantly positive effect on overdoses in all
four specifications. However, the inclusion of state fixed effects, year fixed effects, and both
state and year fixed effects lessened the degree to which expansion led to an increase in
overdoses. The coefficient on overdoses, 5.3, is greatest when both state and year fixed effects
are omitted from the model. When including both state and year fixed effects, there were about
3.1 more overdose deaths in states that had implemented Medicaid expansion compared to states
that did not. Overall, 49% of the variation in unintentional overdose deaths can be explained
from our full specification containing both state and year fixed effects (Specification 4).

II.

Effect of Medicaid Expansion on Suicides
Estimates from the difference-in-differences regression on the effects of Medicaid

expansion on suicides are presented in Table 5. Controlling for sex, marital status, employment
status, healthcare insurance coverage status, race, educational attainment, and income level,
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expansion had a slightly positive but insignificant effect on suicides in all four specifications.
The inclusion of state fixed effects, year fixed effects, and both state and year fixed effects also
lessened the degree to which expansion led to an increase in suicides. When including both state
and year fixed effects, there were less than 0.1 more suicides per 100,000 population in states
that had implemented Medicaid expansion compared to states that did not. Overall, 39% of the
variation in unintentional overdose deaths can be explained from our full specification containing
both state and year fixed effects (Specification 4).

III.

Effect of Medicaid Expansion on Depression Prevalence
Estimates from the difference-in-differences regression on the effects of Medicaid

expansion on deaths from unintentional overdose are presented in Table 6. Controlling for sex,
marital status, employment status, healthcare insurance coverage status, race, educational
attainment, and income level, expansion had a barely significant and slightly positive effect on
depression prevalence when including both state and year fixed effects (Specification 4). The
inclusion of state fixed effects, year fixed effects, and both state and year fixed effects increased
the degree to which expansion led to an increase in overdoses. When including both state and
year fixed effects, the depression prevalence in expansion states was approximately 1.4% higher
than the depression prevalence in states that did not expand. Overall, 57% of the variation in
unintentional overdose deaths can be explained from our full specification containing both state
and year fixed effects (Specification 4).
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CHAPTER SEVEN
CONCLUSIONS
I.

Findings
Surprisingly, Medicaid expansion had a generally negative effect on mental health

outcomes. This effect is most obvious when deaths from accidental overdose are regressed on
Medicaid expansion—I found that expansion states had higher overdose rates than nonexpansion states. It is likely that the worsening of the United States opioid epidemic, in which
drug overdoses more than tripled between 1999 and 2017, is the main reason behind this result.
My estimate for overdoses is similar to the results of Yan et al. (2020), who found that while
Medicaid expansion led to a reduction in mortality not due to drug overdose, drug overdose
deaths increased more in expansion states than non-expansion states. However, my findings also
contrast with Averett et al. (2019) who found that Medicaid expansion did not have a significant
effect on deaths from opioid use. Yan et al. speculated that because Medicaid expansion did not
cause a reduction in deaths until drug overdose deaths were excluded, the opioid epidemic likely
played a role in mitigating the mortality benefit of Medicaid expansion. Overall, I speculate that
the opioid epidemic caused the effect of Medicaid expansion on overdoses to be positive in two
ways. First, it caused the number of overdose deaths during my study period of 2011-2019 to
skyrocket, reducing the expected negative effect of Medicaid expansion on overdose deaths.
Second, by increasing the availability of health resources to the low-income, Medicaid expansion
likely increased the prescription of substances with the potential for abuse such as opioids. These
substances would be more likely to be abused by the demographic covered by Medicaid because
people with lower income are more likely to report having problems related to their substance
abuse compared to individuals with higher income (Baptiste-Roberts & Hossain, 2018). This is
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supported by another study that found that, while Medicaid expansion decreased mortality from
heroin and synthetic opioids other than methadone, it led to an increase in methadone-related
deaths (Kravitz-Wirtz et al., 2020). Methadone is a major treatment for opioid addiction, so
Medicaid expansion may have exacerbated the substance abuse problems of low-income
individuals in states that expanded by increasing the prescription of methadone and other
opioids.
Medicaid expansion did not have a significant effect on suicides. The opioid epidemic
may be part of the reason for this because substance use disorders are associated with a
significantly increased risk of suicide (Bohnert et al., 2017). Thus, the worsening of the opioid
epidemic may have dampened the expected negative impact of Medicaid expansion on suicides.
Furthermore, mental health insurance mandates have been shown to be ineffective at improving
suicide rates (Klick & Markowitz, 2006), although the true reasons why are still unclear. Hence,
even an increase in health coverage associated with Medicaid expansion may not have any
significant effect on suicides.
While we would expect a decrease in depression prevalence to be associated with
Medicaid expansion, I found the opposite to be true. Medicaid expansion was actually associated
with a significant increase in depression prevalence. Because the increase is very slight, I believe
that this estimation is not the result of an increase in depression prevalence, but rather an
increase in the number of diagnoses for depression. By enabling more people to access mental
health services, Medicaid expansion likely increased the number of diagnoses for depression
when in reality the actual number of people with depression may have not changed much. Thus,
while it appears that Medicaid expansion exacerbated depression prevalence, expansion may
have simply been associated with an increase in screening for depression instead.
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Finally, using an estimation of a statistical life-year, $129,090 (Lee et al., 2009) per
quality-adjusted life-year, and the 2019 life expectancy of 78.8 years (Arias et al., 2019), we can
calculate the approximate value of a statistical life to be $10,172,292. This value is important to
understand the approximate economic cost brought on by the implementation of Medicaid
expansion, as is the 2019 United States population of 328.3 million (United States Census
Bureau, 2021c). For overdoses, which increased by 3.113 deaths per 100,000 population, this
translates to about 10,220 deaths in the United States in 2019. The total cost of Medicaid
expansion brought on by overdose deaths was a monumental ten trillion dollars. However, this
estimation is not quite accurate in that it assumes that all people who overdosed died at birth,
which is highly unlikely in the real world. Still, there is a significant economic cost brought on
by expansion’s negative effect on mental health outcomes. We can also calculate the cost
brought on by the decreased life expectancy of those with depression, which has been estimated
to be 8.5 years shorter than the average life expectancy (Gilman et al., 2017). With our estimate
of 0.0135 people with depression prevalence per 100,000 population and the United States
population in 2019, we approximate the United States depression prevalence to be a surprisingly
small 44 people. However, the years of life lost from those with depression associated with
Medicaid expansion is calculated to be 377 years. Ultimately, the economic cost of depression
prevalence associated with Medicaid expansion implementation is calculated to be almost fifty
million dollars, a not-insignificant amount. Overall, our estimations of the economic cost on the
United States economy brought on by poorer mental health outcomes associated with Medicaid
expansion implementation demonstrate that a total of over ten trillion dollars were lost in 2019 as
a result of Medicaid expansion implementation.
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II.

Policy Implications
While Medicaid expansion has been proven to improve physical health outcomes, its

implementation appears to be largely ineffective at combating mental illness. Because expansion
has been shown to exacerbate overdoses, likely by increasing the prescription of opioids,
expansion states should consider enacting stricter laws regarding the prescription of controlled
substances to counteract the increase in substance abuse brought on by expansion. Although my
analysis did not find a positive effect of Medicaid expansion on depression prevalence, it seems
that a beneficial increase in depression screening resulted from expansion. Lawmakers should
consider expanding Medicaid benefits to include screening for a variety of mental illnesses so
that more people with mental illness may be properly diagnosed and subsequently treated. Since
the effect of Medicaid expansion on suicides was inconclusive, it seems that health insurance
legislation is ineffective at addressing suicides. Lawmakers should instead look towards
restructuring the contents of health insurance plans so that they cover more treatments for mental
illness when seeking to prevent suicides.

III.

Suggestions for Future Research
Due to the myriad of counties that had overdose and suicide counts low enough to be

coded as “unreliable” or “suppressed”, our data on these two dependent variables are clouded by
the omission of counties whose populations are not large enough to provide precise counts on the
two variables. Thus, it is necessary to obtain accurate, state-level data on suicides and overdoses
so that a more random and less biased sample may be used to elucidate the effect of Medicaid
expansion on mental health mortality. Additionally, the overdose rate, suicide rate, and rate of
depression of populations in the United States comprise only three variables out of the plethora
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that exists. Future research should investigate other metrics of mental health outcomes for United
States citizens—these can include data on the prevalence of other mental disorders such as
bipolar disorder or schizophrenia. Finally, because the link between health legislation and mental
health outcomes has not yet been widely explored, we should seek to analyze the link between
other health legislation (i.e. the Coronavirus Aid, Relief, and Economic Security Act) and mental
health outcomes to see if such legislation is truly effective at alleviating mental illness. Finally,
the calculated economic costs of ACA Medicaid expansion implementation stemming from its
association with poorer mental health outcomes should be compared to the estimated economic
costs of other health policies in order to further elucidate the efficacy of expansion relative to
other current United States healthcare policies.
As treatments against chronic illness are revolutionized day by day, it is up to the United
States healthcare system to shift its focus onto the ever-present yet insidious problem of poor
mental health. Only then will we have hope to prevent an immeasurable number of deaths and
greatly bolster the micro and macroeconomy of the United States.
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TABLES
Table 1. Descriptive statistics for overdoses
Variable

Mean

Standard Deviation

Minimum

Maximum

21.207

14.427

1.74

149.54

FEMALE

.48

.01

.438

.531

MARRIED

.572

.024

.331

.654

EMPLOYED

.938

.021

.873

.974

COVERAGE

.805

.042

.642

.888

BLACK

.099

.069

.003

.402

ASIAN

.047

.047

.006

.504

OTHER

.06

.049

.012

.342

EDUCATION9

.025

.013

.005

.07

EDUCATIONHS

.256

.044

.098

.379

EDUCATIONC

.317

.031

.132

.401

INCOME10

.142

.022

.095

.205

INCOME12

.42

.047

.189

.531

INCOME22

.295

.026

.217

.376

Dependent Variable

Overdoses

Independent Variables
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INCOME24

.105

.033

.041

.284

INCOME32

.014

.007

.001

.055

INCOME35

.022

.006

.01

.065

INCOME37

.003

.004

0

.017

EXPANDED

.446

.495

0

1

Observations

4115

Notes: Counties with overdose rates that were unreliable or suppressed were excluded from the dataset. Refer to
Chapter 4 for variable definitions.
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Table 2. Descriptive statistics for suicides
Variable

Mean

Standard Deviation

Minimum

Maximum

16.087

6.32

4.26

61.24

FEMALE

.479

.01

.438

.531

MARRIED

.574

.026

.331

.654

EMPLOYED

.937

.022

.873

.978

COVERAGE

.802

.044

.642

.888

BLACK

.099

.072

.002

.402

ASIAN

.047

.052

.003

.504

OTHER

.063

.05

.012

.342

EDUCATION9

.026

.013

.005

.07

EDUCATIONHS

.254

.041

.098

.379

EDUCATIONC

.322

.032

.132

.417

INCOME10

.143

.022

.095

.205

INCOME12

.423

.047

.189

.543

INCOME22

.293

.026

.217

.376

INCOME24

.104

.033

.04

.284

Dependent Variable

Suicides

Independent Variables
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INCOME32

.013

.007

.001

.055

INCOME35

.021

.006

.006

.065

INCOME37

.002

.004

0

.017

EXPANDED

.388

.485

0

1

Observations

4508

Notes: Counties with overdose rates that were unreliable or suppressed were excluded from the dataset. Refer to
Chapter 4 for variable definitions.
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Table 3. Descriptive statistics for depression prevalence
Variable

Mean

Standard Deviation

Minimum

Maximum

.19

.039

0

.5

FEMALE

.479

.014

.438

.531

MARRIED

.576

.043

.331

.654

EMPLOYED

.939

.022

.873

.978

COVERAGE

.807

.049

.642

.888

BLACK

.085

.087

.002

.402

ASIAN

.042

.069

.003

.504

OTHER

.067

.063

.012

.342

EDUCATION9

.021

.01

.005

.07

EDUCATIONHS

.26

.044

.098

.379

EDUCATIONC

.329

.043

.132

.417

INCOME10

.143

.022

.095

.205

INCOME12

.426

.056

.189

.543

INCOME22

.298

.029

.217

.376

INCOME24

.099

.038

.04

.284

Dependent Variable

Depression Prevalence

Independent Variables
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INCOME32

.012

.008

.001

.055

INCOME35

.02

.006

.006

.065

INCOME37

.002

.004

0

.017

EXPANDED

.403

.489

0

1

Observations

459

Notes: Refer to Chapter 4 for variable definitions.
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Table 4. Effect of Medicaid expansion on deaths from unintentional overdose

EXPANDED

FEMALE

MARRIED

EMPLOYED

COVERAGE

BLACK

ASIAN

OTHER

EDUCATION9

EDUCATIONHS

EDUCATIONC

INCOME10

INCOME12

(1)

(2)

(3)

(4)

5.270***

4.379***

3.129***

3.113***

(0.000)

(0.000)

(0.000)

(0.001)

43.31

129.3

77.57*

57.54

(0.240)

(0.072)

(0.029)

(0.427)

-76.01***

-68.51

-12.06

-42.28

(0.000)

(0.143)

(0.335)

(0.396)

193.4***

-52.15

-49.56

80.26

(0.000)

(0.253)

(0.117)

(0.143)

-40.59***

-27.96

-32.24*

-40.83

(0.001)

(0.146)

(0.012)

(0.121)

-37.25***

-114.0**

-57.61***

-131.9**

(0.000)

(0.004)

(0.000)

(0.001)

-4.653

42.61

6.561

-81.62

(0.563)

(0.624)

(0.413)

(0.356)

-37.27***

-83.78

-46.65***

-164.7***

(0.000)

(0.070)

(0.000)

(0.000)

-145.9***

198.4

-183.0***

343.0**

(0.000)

(0.072)

(0.000)

(0.003)

122.2***

-316.5***

78.13***

-205.9***

(0.000)

(0.000)

(0.000)

(0.000)

-63.62***

-175.0**

-128.9***

-27.87

(0.000)

(0.001)

(0.000)

(0.616)

33.99

-404.3*

253.7**

-510.3**

(0.700)

(0.011)

(0.004)

(0.003)

13.45

-247.5

102.1

-587.1***

(0.874)

(0.099)

(0.219)

(0.000)

49

-106.2

-249.9

-21.00

-541.6***

(0.209)

(0.084)

(0.800)

(0.000)

136.8

-438.6*

228.6*

-640.9**

(0.138)

(0.010)

(0.011)

(0.000)

-914.9***

-529.3*

-820.3***

-667.2**

(0.000)

(0.028)

(0.000)

(0.006)

782.6***

142.3

466.6***

-62.22

(0.000)

(0.000)

(0.000)

(0.001)

State Fixed Effects

No

Yes

No

Yes

Year Fixed Effects

No

No

Yes

Yes

0.476

0.371

0.490

INCOME22

INCOME24

INCOME32

INCOME35

Observations

4115

R-squared

0.318

Notes: P-values are presented in parentheses (* p<0.05, ** p<0.01, *** p<0.001). Specification 1 does not contain
state or year fixed effects. Specification 2 contains state fixed effects only. Specification 3 contains year fixed
effects only. Specification 4 contains both state and year fixed effects. The values in the table represent regression
coefficients for each independent variable.
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Table 5. Effect of Medicaid expansion on suicides

EXPANDED

FEMALE

MARRIED

EMPLOYED

COVERAGE

BLACK

ASIAN

OTHER

EDUCATION9

EDUCATIONHS

EDUCATIONC

INCOME10

INCOME12

(1)

(2)

(3)

(4)

0.197

0.205

-0.0557

0.0728

(0.413)

(0.537)

(0.838)

(0.864)

-102.2***

-7.168

-88.29***

-7.066

(0.000)

(0.022)

(0.001)

(0.085)

-35.36***

-45.71*

-18.54***

-36.79

(0.000)

(0.022)

(0.001)

(0.085)

-1.963

-18.66

-52.78***

-28.25

(0.853)

(0.343)

(0.000)

(0.224)

-8.110

8.878

-3.389

9.815

(0.087)

(0.274)

(0.522)

(0.406)

-13.33***

6.145

-17.49***

8.691

(0.000)

(0.731)

(0.000)

(0.648)

-22.07***

-15.10

-19.67***

-27.52

(0.000)

(0.672)

(0.000)

(0.447)

14.46***

-36.58

14.30***

-43.94*

(0.000)

(0.061)

(0.000)

(0.031)

-134.4***

-60.90

-138.4***

-34.95

(0.000)

(0.212)

(0.000)

(0.498)

-12.27*

-24.20

-23.88***

-14.65

(0.013)

(0.247)

(0.000)

(0.527)

7.143

-2.154

-11.14

0.935

(0.229)

(0.923)

(0.078)

(0.968)

157.8***

86.48

227.5***

81.49

(0.000)

(0.218)

(0.000)

(0.276)

305.8***

115.7

361.0***

104.3
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(0.000)

(0.079)

(0.000)

(0.135)

207.5***

117.3

256.2***

102.2

(0.000)

(0.066)

(0.000)

(0.123)

357.5***

136.7

415.3***

124.2

(0.000)

(0.068)

(0.000)

(0.112)

-166.1*

101.1

-149.7*

118.5

(0.022)

(0.342)

(0.039)

(0.274)

346.8***

85.91

308.6***

84.11

(0.000)

(0.145)

(0.000)

(0.161)

State Fixed Effects

No

Yes

No

Yes

Year Fixed Effects

No

No

Yes

Yes

0.385

0.308

0.387

INCOME22

INCOME24

INCOME32

INCOME35

Observations

4508

R-squared

0.297

Notes: P-values are presented in parentheses (* p<0.05, ** p<0.01, *** p<0.001). Specification 1 does not contain
state or year fixed effects. Specification 2 contains state fixed effects only. Specification 3 contains year fixed
effects only. Specification 4 contains both state and year fixed effects. The values in the table represent regression
coefficients for each independent variable.
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Table 6. Effect of Medicaid expansion on depression prevalence

EXPANDED

FEMALE

MARRIED

EMPLOYED

COVERAGE

BLACK

ASIAN

OTHER

EDUCATION9

EDUCATIONHS

EDUCATIONC

INCOME10

INCOME12

(1)

(2)

(3)

(4)

0.00842

0.00333

0.00545

0.0135*

(0.071)

(0.525)

(0.289)

(0.045)

-0.0997

-0.664

-0.0486

-0.605

(0.656)

(0.102)

(0.824)

(0.139)

-0.146*

-0.293

-0.0497

-0.442

(0.049)

(0.219)

(0.502)

(0.087)

0.658***

0.671*

0.0228

0.477

(0.001)

(0.024)

(0.917)

(0.136)

-0.305***

-0.250

-0.173*

0.0761

(0.000)

(0.067)

(0.047)

(0.681)

-0.0722*

-0.552*

-0.110***

-0.545*

(0.021)

(0.025)

(0.001)

(0.027)

-0.0312

0.362

0.0283

0.320

(0.397)

(0.435)

(0.449)

(0.491

-0.192**

-0.199

-0.164**

-0.125

(0.001)

(0.484)

(0.005)

(0.666)

-0.727**

-0.955

-0.922***

-0.840

(0.003)

(0.223)

(0.000)

(0.299)

-0.0856

-0.718*

-0.194*

-0.765*

(0.323)

(0.015)

(0.028)

(0.013)

-0.200*

-0.706*

-0.331**

-0.794**

(0.045)

(0.015)

(0.001)

(0.008)

2.541**

2.157

2.782***

2.423*

(0.001)

(0.067)

(0.000)

(0.045)

2.063**

1.794

2.241**

2.170

(0.006)

(0.110)

(0.002)

(0.059)
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1.964**

1.793

2.031**

2.129

(0.008)

(0.104)

(0.005)

(0.057)

2.168**

1.550

2.256**

1.943

(0.006)

(0.197)

(0.003)

(0.109)

1.124

0.271

1.412

0.893

(0.373)

(0.862)

(0.252)

(0.568)

1.964*

0.148

1.269

0.252

(0.049)

(0.896)

(0.195)

(0.823)

State Fixed Effects

No

Yes

No

Yes

Year Fixed Effects

No

No

Yes

Yes

Observations

459
0.552

0.300

0.573

INCOME22

INCOME24

INCOME32

INCOME35

R-squared

0.240

Notes: P-values are presented in parentheses (* p<0.05, ** p<0.01, *** p<0.001). Specification 1 does not contain
state or year fixed effects. Specification 2 contains state fixed effects only. Specification 3 contains year fixed
effects only. Specification 4 contains both state and year fixed effects. The values in the table represent regression
coefficients for each independent variable.
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